{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:53:08Z","timestamp":1762505588490,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.canrad.2010.02.007","type":"journal-article","created":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T02:21:11Z","timestamp":1272853271000},"page":"363-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dose de tol\u00e9rance \u00e0 l\u2019irradiation des tissus sains\u00a0: la vessie"],"prefix":"10.1016","volume":"14","author":[{"given":"Y.","family":"Pointreau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Atean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Durdux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2010.02.007_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijrobp.2008.04.063","article-title":"Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer","volume":"73","author":"Al Mangaani","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/path.1711430205","article-title":"The subcellular basis of damage to the human urinary bladder induced by irradiation","volume":"143","author":"Antonakopoulos","year":"1984","journal-title":"J Pathol"},{"key":"10.1016\/j.canrad.2010.02.007_bib3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2004.05.033","article-title":"The GETUG 70\u00a0Gy vs 80Gy randomized trial for localized prostate cancer: feasibility and acute toxicity","volume":"60","author":"Beckendorf","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0167-8140(92)90251-O","article-title":"Fractionation sensitivity and latency of late radiation injury to the mouse urinary bladder","volume":"25","author":"Bentzen","year":"1992","journal-title":"Radiother Oncol."},{"key":"10.1016\/j.canrad.2010.02.007_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2007.10.004","article-title":"Ultra-high-dose (86.4Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes","volume":"71","author":"Cahlon","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ijrobp.2006.10.042","article-title":"Investigation of bladder dose and volume factors influencing late urinary toxicity after external radiotherapy for prostate cancer","volume":"67","author":"Cheung","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0360-3016(02)02726-8","article-title":"Urodynamic changes at 18months post-therapy in patients treated with external beam radiotherapy for prostate carcinoma","volume":"53","author":"Choo","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib9","first-page":"345","article-title":"Complications urologiques de la radioth\u00e9rapie","volume":"37","author":"De la Taille","year":"2003","journal-title":"Ann Urol"},{"key":"10.1016\/j.canrad.2010.02.007_bib10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ijrobp.2004.04.017","article-title":"Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114\u00a0patients","volume":"60","author":"De Meerleer","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib11","article-title":"Late functional response of mouse urinary bladder to fractionated X-irradiation","volume":"75","author":"D\u00f6rr","year":"1999","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.canrad.2010.02.007_bib12","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1200\/JCO.2008.19.5776","article-title":"Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06","volume":"27","author":"Efstathiou","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2010.02.007_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2009.08.004","article-title":"Dose-volume effects for normal tissues in external radiotherapy: pelvis","author":"Fiorino","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2010.02.007_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.radonc.2009.03.013","article-title":"Urinary toxicity after high-dose intensity modulated radiotherapy as primary therapy for prostate cancer","volume":"92","author":"Fonteyne","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2010.02.007_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0167-8140(99)00038-9","article-title":"The benefit of beam's eye view based 3-D treatment planning for cervical cancer","volume":"51","author":"Gerstner","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2010.02.007_bib17","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ijrobp.2007.04.076","article-title":"Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive 3-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study","volume":"69","author":"Harsolia","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib18","first-page":"S83","article-title":"GU toxicity after RT for prostate cancer: dose maps and dose surface data to identify dose-effect relationships","volume":"88","author":"Heemsbergen","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2010.02.007_bib19","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1016\/j.juro.2006.07.138","article-title":"Radiation induced late damage to the barrier function of small blood vessels in mouse bladder","volume":"176","author":"Jaal","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2010.02.007_bib20","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.ijrobp.2007.08.076","article-title":"Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity","volume":"70","author":"Karlsdottir","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2004.01.014","article-title":"Acute morbidity related to treatment volume during 3-D conformal radiation therapy for prostate cancer","volume":"71","author":"Karlsdottir","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2010.02.007_bib22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.radonc.2008.04.009","article-title":"Online MRI guidance for healthy tissue sparing in patients with cervical cancer: an IMRT planning study","volume":"88","author":"Kerkhof","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2010.02.007_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/02841869509093956","article-title":"Histological changes after fractionated whole or partial irradiation of the rabbit urinary bladder","volume":"34","author":"Kholer","year":"1995","journal-title":"Acta Oncol"},{"key":"10.1016\/j.canrad.2010.02.007_bib24","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0360-3016(95)00253-7","article-title":"Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3\u00a0prostate cancer","volume":"33","author":"Lebesque","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib25","first-page":"304","volume":"74","author":"Lim","year":"2009","journal-title":"Pelvic radiotherapy for cancer of the cervix: is what you plan actually what you deliver? Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.canrad.2010.02.007_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1748-717X-3-15","article-title":"High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331\u00a0patients","volume":"3","author":"Lips","year":"2008","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2010.02.007_bib27","first-page":"641","volume":"55","author":"Lopez-Beltran","year":"2002","journal-title":"Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer J Clin Pathol"},{"key":"10.1016\/j.canrad.2010.02.007_bib28","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0360-3016(94)00431-J","article-title":"The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy","volume":"31","author":"Marks","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib29","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ijrobp.2004.11.028","article-title":"Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406\u00a0dose level V","volume":"62","author":"Michalski","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib30","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1200\/JCO.2005.07.116","article-title":"Long-term outcomes among localized prostate cancer survivors: heath-related quality of life changes after radical prostatectomy, external radiation and brachytherapy","volume":"23","author":"Miller Dc","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2010.02.007_bib31","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2010.02.007_bib32","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1006\/gyno.2001.6250","article-title":"Initial clinical experience with intensity-modulated whole-pelvic therapy in women with gynecologic malignancies","volume":"82","author":"Mundt","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2010.02.007_bib33","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.juro.2009.06.034","article-title":"Radiation Cystitis","volume":"182","author":"Pavlidakey","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2010.02.007_bib34","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","article-title":"Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68Gy to 78Gy","volume":"61","author":"Peeters","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib35","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response: results of the M","volume":"53","author":"Pollack","year":"2002","journal-title":"D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2010.02.007_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0360-3016(01)01664-9","article-title":"Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation","volume":"51","author":"Portelance","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib37","first-page":"568","article-title":"Prise en charge de la cystite radique","volume":"14","author":"Rigaud","year":"2004","journal-title":"Prog Urol"},{"key":"10.1016\/j.canrad.2010.02.007_bib38","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2002.11.027","article-title":"Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results","volume":"20","author":"Rodel","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2010.02.007_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0360-3016(96)00468-3","article-title":"Late GI and GU complications in the treatment of prostate cancer","volume":"37","author":"Schultheiss","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib40","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijrobp.2006.12.064","article-title":"Patient-assessed late toxicity rates and principal component analysis after image guided radiation therapy for prostate cancer","volume":"68","author":"Skala","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib41","doi-asserted-by":"crossref","unstructured":"Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique. Guides des proc\u00e9dures de radioth\u00e9rapie externe 2007.. Cancer Radiother 2008;12:143\u2013313.","DOI":"10.1016\/j.canrad.2008.02.001"},{"key":"10.1016\/j.canrad.2010.02.007_bib42","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0360-3016(01)02748-1","article-title":"On the consistent use of organ definitions and radiobiological models for the evaluation of complication probabilities of tubular organs","volume":"52","author":"Stavrev","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib43","first-page":"280","article-title":"Mechanism of bladder damage and repair after treatment with radiation and cytoxic drugs","volume":"7","author":"Stewart","year":"1986","journal-title":"Br J Cancer Suppl"},{"key":"10.1016\/j.canrad.2010.02.007_bib44","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0360-3016(00)00700-8","article-title":"Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial","volume":"48","author":"Storey","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib45","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0360-3016(97)00312-X","article-title":"Dose-volume histograms for bladder and rectum","volume":"38","author":"Ting","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.canrad.2010.02.007_bib47","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0360-3016(03)00640-0","article-title":"RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3-D conformal radiation therapy for prostate cancer associated with treatment toxicity?","volume":"57","author":"Valicenti","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib48","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","article-title":"Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer","volume":"70","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2010.02.007_bib49","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2460::AID-CNCR23>3.0.CO;2-N","article-title":"Long-term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma","volume":"85","author":"Zelefsky","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2010.02.007_bib50","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/01.ju.0000093721.23249.c3","article-title":"Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors","volume":"170","author":"Zietman","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.canrad.2010.02.007_bib51","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"JAMA"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321810000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321810000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:16:32Z","timestamp":1761135392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321810000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":51,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1278321810000417"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2010.02.007","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose de tol\u00e9rance \u00e0 l\u2019irradiation des tissus sains\u00a0: la vessie","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2010.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}